Cox Enterprises led a $58m round for healthcare delivery software provider Enlace Health while Johnson & Johnson snapped up portfolio company OrthoSpin for almost $80m.

Alibaba, Ant Financial and Berkshire Hathaway are among the anchor investors for a provision set to make up nearly half of the payment platform developer's $2.45bn target for its IPO.

FTV Capital provided the Restaurant Group-backed payment platform developer with fresh capital that will be used to boost its expansion across new industries.

FTX and Binance came on board for the game monetisation software developer’s series C round, taking its total funding to $270m.

Ubicom Holdings Japan helped gynaecological imaging software developer Illumigyn take its total funding to $33m while Optum took part in a $30m round for health payment technology provider Medallion.

The business management software developer hiked its overall funding to $465m and its valuation to $2.4bn in a Citi Ventures-backed round.

Hillel Olivestone, Cross River’s head of corporate development, will run unit.

Cox Enterprises invested in digital media company Axios at a $430m valuation while Bristol Myers Squibb helped enzyme drug developer Nitrase Therapeutics boost its series A round to $45m.

The Tencent and Berkshire Hathaway-backed digital bank is seeking to grow its valuation from $30bn in June to over $50m in flotations in the US and Brazil.

FTX helped Chipper add $150m to a series C round valuing the cross-border payment platform developer at over $2bn.